Wednesday, November 18, 2026
Data from SEC filings, checked daily
My DeskFree
Public filings, plainly told
Opportunistic Insider Buying
Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
Screen742 buys, 90 days

Opportunistic Insider Buying

Most insider trades follow a calendar. These purchases did not: the insider has traded every year, but not usually in this month. That is the kind of trade research has tied to future returns.

Latest opportunistic purchases

StockInsiderTradedValue3 months vs S&P 500
LEN LENNAR CORP /NEW/Berkshire Hathaway Inc 10% ownerSep 18, 2026$105.6M—
KOD Kodiak Sciences Inc.Baker Bros. Advisors LP DirectorSep 28, 2026$60.5M—
KOD Kodiak Sciences Inc.Baker Bros. Advisors LP DirectorSep 28, 2026$58.6M—
LEN LENNAR CORP /NEW/Berkshire Hathaway Inc 10% ownerSep 17, 2026$54.9M—
LEN LENNAR CORP /NEW/Berkshire Hathaway Inc 10% ownerSep 24, 2026$52.8M—
LEN LENNAR CORP /NEW/Berkshire Hathaway Inc 10% ownerSep 30, 2026$52.4M—
LEN LENNAR CORP /NEW/Berkshire Hathaway Inc 10% ownerSep 21, 2026$51.9M—
MGM MGM Resorts InternationalKeith A. Meister DirectorOct 30, 2026$51.5M—
LEN LENNAR CORP /NEW/Berkshire Hathaway Inc 10% ownerSep 23, 2026$43.6M—
PEPG PepGen Inc.Ra Capital Management, L.P. DirectorNov 13, 2026$43.1M—
BBTX Bambusa Therapeutics, Inc.Ra Capital Management, L.P. DirectorNov 2, 2026$40.0M—
LEN LENNAR CORP /NEW/Berkshire Hathaway Inc 10% ownerSep 25, 2026$39.9M—
EMO ClearBridge Energy Midstream Opportunity Fund Inc.Prudential Financial Inc 10% ownerNov 12, 2026$35.0M—
KOD Kodiak Sciences Inc.Baker Bros. Advisors LP DirectorSep 28, 2026$35.0M—
FTK FLOTEK INDUSTRIES INC/CN/Matthew Wilks DirectorSep 11, 2026$34.3M—
PAMT PAMT CORPMatthew T. Moroun DirectorSep 3, 2026$31.2M—
GSAT Globalstar, Inc.James Monroe III DirectorSep 18, 2026$29.8M—
MDGL MADRIGAL PHARMACEUTICALS, INC.Baker Bros. Advisors LP DirectorNov 6, 2026$29.3M—
ETRA Electra Therapeutics, Inc.Carl L. Gordon DirectorSep 21, 2026$20.0M—
ADRX ADARx Pharmaceuticals, Inc.Carl L. Gordon DirectorSep 28, 2026$16.1M—
USO United States Oil Fund, LPHrt Financial LP 10% ownerSep 14, 2026$16.0M—
KOD Kodiak Sciences Inc.Baker Bros. Advisors LP DirectorNov 4, 2026$15.8M—
ASPE Aspen Neuroscience, Inc.Peter A. Thompson DirectorNov 2, 2026$15.0M—
UBER Uber Technologies, IncDara Khosrowshahi Chief Executive OfficerSep 10, 2026$10.0M—
STWD STARWOOD PROPERTY TRUST, INC.Barry S. Sternlicht CEO, Chairman of the BoardNov 11, 2026$9.89M—
INTC INTEL CORPLip Bu Tan CEONov 2, 2026$9.71M—
KOD Kodiak Sciences Inc.Baker Bros. Advisors LP DirectorNov 5, 2026$8.51M—
ENHA Enhanced Group Inc.Apeiron Investment Group Ltd. DirectorSep 17, 2026$6.99M—
USO United States Oil Fund, LPHrt Financial LP 10% ownerSep 16, 2026$6.78M—
BBTX Bambusa Therapeutics, Inc.Ra Capital Management, L.P. DirectorOct 30, 2026$6.64M—
ARDC Ares Dynamic Credit Allocation Fund, Inc.Financial For Lutherans Thrivent 10% ownerSep 14, 2026$6.00M—
ALMS ALUMIS INC.Srinivas Akkaraju DirectorSep 8, 2026$5.81M—
MDGL MADRIGAL PHARMACEUTICALS, INC.Baker Bros. Advisors LP DirectorNov 4, 2026$5.76M—
OFIX Orthofix Medical Inc.Juniper Investment Company, LLC 10% ownerNov 9, 2026$5.00M—
CRAFX Cascade Real Assets FundStephen Lane Nesbitt PresidentSep 21, 2026$5.00M—
ALMS ALUMIS INC.Srinivas Akkaraju DirectorSep 4, 2026$4.92M—
STWD STARWOOD PROPERTY TRUST, INC.Barry S. Sternlicht CEO, Chairman of the BoardNov 12, 2026$4.81M—
KBDC Kayne Anderson BDC, Inc.James L. Robo DirectorSep 16, 2026$4.43M—
ANGX Angel Studios, Inc.Steven I. Sarowitz DirectorNov 16, 2026$3.94M—
PSEC PROSPECT CAPITAL CORPJohn F. Barry CHIEF EXECUTIVE OFFICERNov 9, 2026$3.93M—
BH Biglari Holdings Inc.Sardar Biglari Chairman and CEONov 12, 2026$3.78M—
SIRI SIRIUS XM HOLDINGS INC.Berkshire Hathaway Inc 10% ownerNov 3, 2026$3.43M—
CTY CITY THERAPEUTICS, INC.Robert Nelsen DirectorOct 19, 2026$3.06M—
LLYVK Liberty Live Holdings, Inc.John C. Malone 10% ownerSep 24, 2026$2.90M—
KOD Kodiak Sciences Inc.Baker Bros. Advisors LP DirectorSep 29, 2026$2.87M—
ENHA Enhanced Group Inc.Apeiron Investment Group Ltd. DirectorAug 19, 2026$2.78M—
AKAM AKAMAI TECHNOLOGIES INCF. Thomson Leighton Chief Executive OfficerNov 13, 2026$2.55M—
SLGL Sol-Gel Technologies Ltd.Opaleye Management Inc. 10% ownerAug 28, 2026$2.43M—
PSEC PROSPECT CAPITAL CORPJohn F. Barry CHIEF EXECUTIVE OFFICERNov 10, 2026$2.13M—
SIRI SIRIUS XM HOLDINGS INC.Berkshire Hathaway Inc 10% ownerNov 2, 2026$1.97M—
ETRA Electra Therapeutics, Inc.Carl L. Gordon DirectorNov 3, 2026$1.93M—
KBDC Kayne Anderson BDC, Inc.James L. Robo DirectorSep 28, 2026$1.91M—
ANGX Angel Studios, Inc.Steven I. Sarowitz DirectorSep 10, 2026$1.88M—
BH Biglari Holdings Inc.Sardar Biglari Chairman and CEONov 11, 2026$1.76M—
PSEC PROSPECT CAPITAL CORPJohn F. Barry CHIEF EXECUTIVE OFFICERNov 6, 2026$1.73M—
CTEV Claritev CorpAres Management LLC 10% ownerNov 10, 2026$1.71M—
OFIX Orthofix Medical Inc.Juniper Investment Company, LLC 10% ownerSep 21, 2026$1.68M—
ROK ROCKWELL AUTOMATION, INCBlake D. Moret President and CEONov 9, 2026$1.55M—
ADC AGREE REALTY CORPJohn Rakolta Jr DirectorAug 27, 2026$1.46M—
CACC CREDIT ACCEPTANCE CORPThomas N. Tryforos DirectorNov 2, 2026$1.46M—

Routine or opportunistic: what happened next

Every open-market trade on file, three months after the trade date, against the S&P 500 and against the equal-weight S&P 500 (every company in the index at the same weight, the fairer yardstick for the smaller companies insiders mostly buy). For sales, a negative number means the stock did worse than the market after the insider sold. The choice of index moves every row up or down together, so it changes the levels more than the gap between opportunistic and routine; whether the two groups hold different kinds of company is tested further down.

Kind of tradePurchasesMedian vs S&P 500vs equal-weight S&PBeat the S&P 500SalesMedian vs S&P 500
Opportunistic
traded in each of the last three years, not usually in this month
3,630
809 companies
−1.0%+0.3%47%17,433−3.5%
Routine
traded in this same month in each of the last three years
2,346
173 companies
−4.9%−3.1%34%6,896−2.6%
Not classified
too little trading history to tell
13,518
2,430 companies
−2.7%−1.9%44%41,105−4.6%

Did the stock just fall?

The same purchases, split by what the stock did in the four weeks before the buy. Stocks that fell hard often bounce in the following months whoever buys them, so an edge that lives only in the first row is partly a rebound anyone could have bought. An edge that holds in the last row is closer to information. Under each median is the median per company, so a few companies buying every month do not count as many separate results.

Kind of purchaseStock in the 4 weeks beforePurchasesMedian vs S&P 500, 3 monthsBeat the S&P 500
OpportunisticFell more than 15%423
180 companies
−5.0%
−3.0% per company
43%
Fell 0% to 15%1,139
408 companies
−0.3%
−0.7% per company
49%
Flat or rose1,297
396 companies
−1.3%
−0.4% per company
47%
RoutineFell more than 15%133
17 companies
−24.4%
−4.2% per company
14%
Fell 0% to 15%849
95 companies
−5.7%
−4.1% per company
32%
Flat or rose921
93 companies
−4.4%
−4.8% per company
35%

Is it the label, or the kind of company?

Routine buyers may simply sit in different companies: smaller ones, or more banks. If so, part of the gap above is a size or sector effect, not information. Here the same purchases are measured three ways: against the S&P 500, against the company's sector ETF (regional banks against KRE, biotech against XBI, and so on, from the SEC industry code), and against an index of companies its size (IWM under $2 billion in market value, IJH from $2 to $10 billion, the S&P 500 above). Each figure is the median per company, three months after the purchase. Only purchases with all three figures count.

Stock in the 4 weeks beforeKindCompaniesvs S&P 500vs sector ETFvs same-size indexBanks / small caps
All purchasesOpportunistic577+0.6%+2.0%+0.6%18% / 69%
Routine112−1.8%+0.1%−2.2%36% / 71%
Gap+2.4%+1.9%+2.8%
Fell more than 15%Opportunistic138−1.6%−3.5%−1.8%2% / 78%
Routine13
small sample
−4.2%−10.2%−4.2%0% / 69%
Gap+2.6%+6.7%+2.5%
Fell 0% to 15%Opportunistic285+1.3%+1.7%+1.8%19% / 67%
Routine59−3.3%−1.5%−0.6%27% / 61%
Gap+4.6%+3.2%+2.4%
Flat or roseOpportunistic284+1.6%+2.8%+0.9%23% / 63%
Routine61−4.5%−1.7%−3.9%43% / 69%
Gap+6.1%+4.5%+4.8%

Gap = opportunistic minus routine, in percentage points. If it holds up against the sector and size benchmarks, the difference is not explained by routine buyers sitting in smaller companies or in banks. The last column is the share of companies in each group that are banks (measured against KRE) and that are under $2 billion in market value.

A lone buyer or a group? A top-up or a big bet?

Two more cuts of the same purchases. Each row is one buy event: one insider, one stock, one trade date. "With other insiders" means at least one other insider of the same company bought within 7 days either side. The size of the bet is the shares bought against the shares the insider already held directly, from the holdings line on the same Form 4; "first shares held" means the insider held none directly before. Every figure is the median per company (each company's own median, then the median of those), three months after the purchase, against the S&P 500. Cells with fewer than 5 companies show no figure.

Alone or with other insiders

Stock in the 4 weeks beforeBuysCompaniesMedian per companyBeat the S&P 500Opportunistic only
All purchasesAlone10,4222,346−1.8%42%−0.7%
601 cos.
With 1 other insider3,108753−0.6%44%+1.0%
240 cos.
With 2 or more5,197625−0.3%45%−0.3%
239 cos.
Fell more than 15%Alone1,270544−2.3%38%−3.6%
128 cos.
With 1 other insider432174+1.0%50%+3.5%
32 cos.
With 2 or more816158−4.5%46%−0.6%
36 cos.
Fell 0% to 15%Alone3,3371,196−1.8%41%−0.6%
267 cos.
With 1 other insider1,020349−2.2%44%+0.0%
108 cos.
With 2 or more1,554283−2.1%44%−1.4%
104 cos.
Flat or roseAlone3,7671,255−1.4%44%−1.3%
294 cos.
With 1 other insider971312+0.3%45%+3.3%
94 cos.
With 2 or more1,518231−0.1%42%−0.7%
87 cos.

Size of the buy against the existing stake

Stock in the 4 weeks beforeBuysCompaniesMedian per companyBeat the S&P 500Opportunistic only
All purchasesUnder 10% added8,9311,519−0.8%42%−0.5%
431 cos.
10% to 49%2,4141,126−1.1%44%+0.2%
196 cos.
50% to 99%637464+0.9%48%+5.8%
49 cos.
Doubled or more711528−2.7%42%−3.5%
52 cos.
First shares held978620−4.7%39%−5.7%
51 cos.
Fell more than 15%Under 10% added1,174386−2.0%40%−2.6%
87 cos.
10% to 49%371259+1.5%49%−2.5%
29 cos.
50% to 99%10691+1.7%52%−15.1%
8 cos.
Doubled or more113101−4.1%44%−2.8%
6 cos.
First shares held125101−1.6%46%−5.7%
7 cos.
Fell 0% to 15%Under 10% added2,903804−0.3%42%−1.1%
214 cos.
10% to 49%761472−1.5%42%+2.6%
72 cos.
50% to 99%213172−1.5%47%+4.9%
15 cos.
Doubled or more236193−4.0%40%−3.7%
21 cos.
First shares held249190−5.8%37%−7.8%
15 cos.
Flat or roseUnder 10% added3,102771−0.6%41%+0.3%
217 cos.
10% to 49%798465−1.0%44%+1.2%
83 cos.
50% to 99%202162+0.3%48%+14.7%
14 cos.
Doubled or more214180−2.6%41%−2.3%
20 cos.
First shares held296229−5.6%35%−6.2%
16 cos.

All open-market purchases count here, classified or not; the last column keeps only opportunistic buys. A filing can report holdings on more than one line (directly, through a trust, a spouse), so the size test uses the direct line only and leaves out buys made only indirectly.

Planned in advance or not?

Since April 2023 Form 4 has a checkbox for trades made under a Rule 10b5-1 plan, which is set up months ahead. A plan purchase in a stock that has just crashed was decided before the crash, so it says little about what the insider thinks now. Purchases from April 2023 on, three months after the trade, against the S&P 500. Groups under 10 purchases show no figure. Under each count is the number of companies, and under each median the median per company (each company's own median, then the median of those), so a few companies buying every month do not count as many separate results.

Kind of purchasePlanAfter a drop of 15%+MedianBeatAll purchasesMedianBeat
OpportunisticUnder a 10b5-1 plan5
3 companies · small sample
——141
24 companies
+1.8%
+5.9% per company
54%
No plan418
178 companies
−5.3%
−3.0% per company
43%3,489
795 companies
−1.1%
−0.6% per company
47%
RoutineUnder a 10b5-1 plan44
1 company · small sample
−29.0%0%212
8 companies · small sample
−26.4%
−2.5% per company
10%
No plan89
17 companies
−17.2%
−4.2% per company
20%2,134
169 companies
−4.0%
−3.4% per company
36%

What "opportunistic" means

Lauren Cohen, Christopher Malloy and Lukasz Pomorski (Journal of Finance, 2012) split insiders by their calendar. An insider who traded in the same month in each of the previous three years is routine: the trade is probably habit, a bonus being paid, or a plan. One who traded in each of those years but not always in that month is opportunistic. Everyone else is left unclassified.

In their data, routine trades were more than half of all insider trades and a portfolio built on them earned essentially nothing extra. A portfolio built on opportunistic trades earned abnormal returns of 82 basis points a month, value-weighted.

What to keep in mind

Our version uses open-market purchases and sales (Form 4 codes P and S), credited to the first reporting owner on each filing. History before our own daily files comes from the SEC's quarterly Insider Transactions Data Sets. The study's results come from decades of past data; a single opportunistic purchase can still go wrong, and the table above is a live check of whether the pattern is holding today.

Source: SEC Form 4 filings on EDGAR and the SEC Insider Transactions Data Sets. Prices are weekly closes adjusted for splits; trades whose filings look mistyped are left out. Not investment advice. See also our study of opportunistic and routine buys and insider buying against the S&P 500.

Report an error

Tell us what looks wrong on this page. We check every report against the original filing and fix mistakes on our corrections page.

Share this trade
XTelegram
My Desk · free

Sign in to follow

Follow stocks, members of Congress, famous investors and funds, and see what's new each time you come back.